Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

(NASDAQ:VXRT), SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today announced that it has received approval from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), to initiate dosing in […]

Heidelberg Materials invests in upgrades to cement distribution terminal in Cementon, New York

Irving, Texas, May 15, 2025 (GLOBE NEWSWIRE) — Heidelberg Materials North America is pleased to announce important upgrades to its cement distribution terminal in Cementon, New York. These upgrades include a new packaging line for bagged products, increased cement storage and a new fully automated palletizing system. The new rotary packing machine, supplied by Haver

Lilypad Insurance Selects BriteCore to Power Policy Administration and Fuel Coastal Market Expansion

San Mateo, CA, May 15, 2025 (GLOBE NEWSWIRE) — BriteCore, the leading cloud-native core insurance platform for property and casualty (P&C) insurers, today announced that Lilypad Insurance, a provider of tailored homeowners coverage for coastal communities, has selected BriteCore as its policy administration platform. Focused on delivering peace of mind to homeowners in hurricane-prone and

John Textor’s $2 billion Eagle Football Holdings IPO filing ‘imminent’ according to London’s City AM; Bloomberg reports UBS working on first large-cap IPO of a Multi-Club Ownership (MCO) group

(NASDAQ:BREA), Brera Holdings' Executive Chairman Dan McClory (left) and Eagle Football Holdings' John Textor (right) at the Financial Times Business of Football Summit in 2024 Dublin, Ireland and Milan, Italy, May 15, 2025 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings,” “Brera” or the “Company”) (Nasdaq: BREA), an Ireland-based international holding company focused on expanding

HVR Launches “Utility Now!” Campaign at the Debut of Global Web3 Event Series — Not the One to Miss

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) — As Consensus Toronto draws the world's leading voices in blockchain and decentralized finance, Not the One to Miss is where many of Web3's most ambitious builders and personalities will be heading after hours. Hosted by HVR and co-hosted by WonderFi, Lazer Technologies, GDA Capital, Houdini Swap, Joinable AI,

Fresca Group Selects insightsoftware to Transform its Financial Consolidation and Disclosure Management Processes

RALEIGH, N.C., May 15, 2025 (GLOBE NEWSWIRE) — insightsoftware, the most comprehensive provider of solutions for the Office of the CFO, today announced Fresca Group, one of the UK's largest fresh produce businesses, will deploy JustPerform from insightsoftware. Fresca chose insightsoftware for its ability to offer a comprehensive EPM solution. Implementing this solution enables Fresca

Nuvini Group Completes Acquisition of B2B SaaS Platform Munddi

(NASDAQ:NVNI), ~ Successfully Marks the First of Four Anticipated Acquisitions in 2025 ~ ~ Creates New Synergies to Drive Revenue Growth and Enhance NVNI's Ecosystem of B2B SaaS Solutions across Latin America ~ NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) — Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private

Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

(NASDAQ:COCP), In vitro testing with CDI-988 demonstrated superior broad-spectrum antiviral activity against major norovirus variants BOTHELL, Wash., May 15, 2025 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three months ended March 31, 2025, and provides updates on its antiviral product pipeline, upcoming milestones and business

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

(NASDAQ:PHAT), FLORHAM PARK, N.J., May 15, 2025 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that the company is scheduled to participate in the following investor conferences in May and June: H.C. Wainwright 3rd Annual BioConnect Investor Conference at

Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) — Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, today announced its $365 million Series D financing, bringing its post-money valuation to approximately $1.6 billion. This financing marks a major milestone for Pathos as it expands its AI-enabled platform to drive greater

Scroll to Top